On August 31, 2018, the official website of the National Medical Products Administration issued the "Administrative Measures for Monitoring and Re-evaluation of Medical Device Adverse Events" (State Administration for Market Regulation Order No. 1) (hereinafter referred to as the "Measures"). The Measures put forward a series of new work requirements for medical device registrants, including writing regular risk assessment reports for post-market medical devices.
